Advertisement
Advertisement
INTS
Intensity Therapeutics, Inc. Common stock
2.12
USD+0.02
+1.14%
Feb 21, 15:59 UTC -5
Closed
Pre-Market
2.225
0
-0.22%
Intensity Therapeutics, Inc. Common stock Profile
About
Info & Links
CEO
Lewis H. Bender
Headquarters
SHELTON, CT 06484, UNITED STATES
Industry
Sector
Auditor
EisnerAmper LLP
Share holders
--
Employees
7
Intensity Therapeutics, Inc. Common stock Statistics
Valuation Measures
Market Capitalization2
30.86M
Enterprise Value
28.22M
Enterprise Value/EBITDA(ttm)
-1.69
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
10.90
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
0.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
0.00%
Return on Equity(ttm)
-209.73%
Return on Invested Capital(ttm)
-282.77%
Return on Assets(ttm)
-149.19%
Income Statement
Revenue(ttm)
0.00
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
0.00
EBITDA(ttm)3
-16.71M
Net Income Available to Common(ttm)
-16.26M
Diluted EPS(ttm)
-1.07
Share Statistics
Beta (5Y Monthly)
4.03
52-Week Change
-33.12%
S&P 500 52-Week Change
18.61%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
13.87M
Dividend Yield
0.00%
Float4
12.29M
% Held by Insiders
18.60%
% Held by Institutions
3.74%
Balance Sheet
Total Cash(mrq)
2.78M
Total Cash Per Share(mrq)
0.20
Total Debt(mrq)
145.00K
Total Debt/Equity(mrq)
5.22%
Current Ratio(mrq)
1.63%
Quick Ratio(mrq)
1.63%
Book Value Per Share(mrq)
0.20
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.91
Free Cash Flow(ytd)
-12.55M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement